KRAS and colorectal carcinoma: Through the CC approach, the nine CRC patients were divided into two subgroups, comprising five cases in subgroup 1 and four cases in subgroup 2; notably, subgroup 1 housed two cases of KRAS wild-type CRC patients, whereas subgroup 2 accommodated two cases of KRAS mutant CRC patients, as illustrated in Fig. S1B.